INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Feb 27, 2020 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Open market or private sale of non-derivative or derivative security | 31 | $468.56 | 11,380 |
Feb 26, 2020 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Bona fide gift | 750 | -- | 20,979 |
Feb 26, 2020 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | -- | 38,079 |
Feb 26, 2020 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | $52.03 | 36,380 |
Feb 26, 2020 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 14,651 | $451.89 | 21,729 |
Feb 14, 2020 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 5,736 |
Feb 14, 2020 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 7,831 |
Feb 14, 2020 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 13,700 |
Feb 13, 2020 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Open market or private sale of non-derivative or derivative security | 4,302 | $399.80 | 17,356 |
Feb 13, 2020 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Open market or private sale of non-derivative or derivative security | 2,608 | $400.54 | 14,748 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.